Related Experiment Video

Updated: Mar 19, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K

The inaugural HEMA report: a missed opportunity for comprehensive value assessment

Kimberly Westrich1, Tyler D Wagner1, Jonathan D Campbell1

  • 1National Pharmaceutical Council, Washington, DC, 20006, USA.

Journal of Comparative Effectiveness Research
|March 18, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
economic evaluationhealth technology assessmentopportunity costpatient-centered outcomesvalue assessment

More Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.8K
Quantification of Humic and Fulvic Acids in Humate Ores, DOC, Humified Materials and Humic Substance-Containing Commercial Products12:55

Quantification of Humic and Fulvic Acids in Humate Ores, DOC, Humified Materials and Humic Substance-Containing Commercial Products

Published on: March 18, 2022

20.3K

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
356